Massachusetts Financial Services
BEAM icon

Massachusetts Financial Services’s Beam Therapeutics BEAM Stock Holding History

Massachusetts Financial Services’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-55,465
Closed -$943K – 864
2025
Q2 		$943K Buy
55,465
+686
+1% +$11.9K ﹤0.01% 813
2025
Q1 		$1.07M Sell
54,779
-1,248
-2% -$32.7K ﹤0.01% 804
2024
Q4 		$1.39M Sell
56,027
-1,671
-3% -$42.6K ﹤0.01% 787
2024
Q3 		$1.41M Sell
57,698
-1,397
-2% -$36.1K ﹤0.01% 769
2024
Q2 		$1.38M Buy
+59,095
New +$1.45M ﹤0.01% 776
2023
Q2 		– Sell
-10,409
Closed -$319K – 828
2023
Q1 		$319K Sell
10,409
-10,498
-50% -$414K ﹤0.01% 821
2022
Q4 		$818K Buy
20,907
+1,557
+8% +$69.7K ﹤0.01% 791
2022
Q3 		$922K Buy
+19,350
New +$1.1M ﹤0.01% 788

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Massachusetts Financial Services's BEAM Position: Q3 2025 in Review

Massachusetts Financial Services sold out of Beam Therapeutics (BEAM) in Q3 2025, closing a stake of 55,465 shares — an estimated $943K sold.

Massachusetts Financial Services first reported a position in BEAM in Q3 2022 and held it in 8 quarters. The position peaked at $1.41M in Q3 2024. 219 funds tracked by Wall St. Rank hold BEAM as of Q3 2025.

  • Massachusetts Financial Services reported no remaining Beam Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Massachusetts Financial Services sold 55,465 Beam Therapeutics shares in Q3 2025, an estimated $943K.
  • Massachusetts Financial Services first reported a position in Beam Therapeutics in Q3 2022 and held it in 8 quarters.
  • Massachusetts Financial Services's Beam Therapeutics position peaked at $1.41M in Q3 2024.
  • 219 funds tracked by Wall St. Rank held Beam Therapeutics as of Q3 2025.

Based on Massachusetts Financial Services's 13F filing for Q3 2025, filed 29 Oct 2025.